Compare 34 healthcare IT platforms independently reviewed by health system CIOs, clinical informatics, and revenue cycle leaders. Epic and Oracle Health (Cerner) dominate the acute-care EHR market; Meditech and Allscripts (Veradigm) remain significant. Athenahealth, eClinicalWorks, and NextGen lead ambulatory deployments. Filter by deployment setting, organisation size, interoperability, and revenue cycle integration. Every review is verified. No vendor pays for ranking.
The US healthcare IT market exceeded $80B in 2025 across EHR, RCM, interoperability, analytics, and patient engagement, per HIMSS and Black Book benchmarks. Adoption is now near-universal in acute care; spend is shifting from EHR replacement to optimisation, interoperability, ambient AI documentation, and revenue cycle automation.
Epic retains the largest share of acute hospital beds in the United States and continues to win net-new replacements from Oracle Health (Cerner) and other competitors. Meditech Expanse remains strong in community hospitals. The ambulatory market is more fragmented, with athenahealth, eClinicalWorks, and specialty-focused platforms (ModMed, Compulink, Elation) competing aggressively.
The most consequential 2026 capability is ambient AI scribing and clinical summarisation, with Microsoft DAX, Nuance, and Suki integrated natively or as marketplace partners. TEFCA and FHIR-based interoperability are reshaping data exchange. Pair healthcare IT with CTMS, GRC, AI, or explore the software directory. Compare Epic vs Oracle Health or read Best EHR for Small Ambulatory Practices.
Index.Html is one of several options in the Healthcare It Systems category on TechVendorIndex. The right way to evaluate it is in the context of your specific buyer profile rather than in isolation: who in your organisation will use it day-to-day, what scale of deployment you need, what existing systems it has to integrate with, and which capabilities are non-negotiable for your use case. Index.Html's strengths land best for buyers who match a particular profile; the related pages and comparisons surface the trade-offs against the most common alternatives so a buyer can decide quickly whether to keep it on the shortlist or rule it out.
Buyers who shortlist Index.Html typically focus their proof-of-concept on three things: depth of functionality in the specific use case that triggered the project, real-world performance and stability under representative load, and the practical experience of integrating with the rest of the existing stack. Vendor-provided demonstration environments rarely surface integration friction, identity-management edge cases, or data-volume scaling limits. A structured pilot against a representative slice of your own data is the single highest-leverage step in the evaluation.
The list price for Index.Html is only one element of the three-year total cost of ownership. Buyers also need to estimate implementation services, internal team time, integration platform fees, training and change-management costs, and any adjacent tooling required to make the product useful in the buyer's specific environment. Vendors often offer attractive year-one pricing that does not reflect the true ongoing cost; ask explicitly for a three-year quote with assumptions documented before signing.
Each profile on TechVendorIndex is reviewed at the same cadence as the parent category. Index.Html's position in the Healthcare It Systems category may shift as competing products release new capabilities, as Index.Html itself releases new versions, or as pricing models change. Buyers who selected Index.Html more than two years ago may want to re-evaluate even if the product is meeting needs today.